Read these details about Vectus and C14:
AUG 2024: Vectus and C14
https://www.listcorp.com/asx/vbs/vectus-biosystems-limited/news/agreement-with-c14-consulting-group-3077597.htmlApril 2025: Similar to BIT and waiting for Chiense Companies
https://www.listcorp.com/asx/vbs/vectus-biosystems-limited/news/quarterly-activities-and-amp-appendix-4c-cash-flow-reports-3183626.htmlhttps://hotcopper.com.au/threads/ann-quarterly-activities-appendix-4c-cash-flow-reports.8560446/
VBS is not raising any capital despite no money for salary.
"
Finance and Corporate:
Vectus has significantly reduced its operating costs,and is now largely focussed on potential licencing opportunities and a variety of collaborations. The funds expended by the Company during the March2025quarter were alsoin connection with the finalisation of the Phase I clinical trials for VB0004. Payments for commercialisation, Phase I, research, patents, staff costs and a Director’sfeefor the quarter amounted to $381,000. Cash-on-hand at 31 March2025 was $370,000. Payments to related parties during the recent quarter were the payment of$124,000 to the estate of the late Chief Executive Officerof Vectus, Dr Karen Duggan, being the balance of entitlementsowing,and aNon-Executive Director’s fee of $7,000.The Company continues to evaluate a number of options to address its future capitalrequirements and is examining the opportunity for potential partners or licencees to fundfurther clinical studies. "
From VBS, no letter of Voluntary admin so far despite no CR and no money to run the company.
